Other Species / Isoforms
  TAB1 (human)      LTP 

LTP (Low Throughput Papers) : The number of records in which this modification site was determined using methods other than discovery mass spectrometry.

 HTP 

HTP (High Throughput Papers): The number of records in which this modification site was assigned using ONLY proteomic discovery mass spectrometry.

 
S7-p
_MAAQRRsLLQsEQQ
Upstream
0 24
Treatment
  • BI2536
  • ischemia
  • MLN8054
TAB1 (human) _MAAQRRsLLQsEQQ S7-p
TAB1 iso2 (human) _MAAQRRSLLQSEQQ S7
TAB1 (mouse) _MAAQRRsLLQsEQQ S7-p
TAB1 (rat) _MAAQRRSLLQSEQQ S7
S11-p
QRRsLLQsEQQPsWT
0 3
TAB1 (human) QRRsLLQsEQQPsWT S11-p
TAB1 iso2 (human) QRRSLLQSEQQPSWT S11
TAB1 (mouse) QRRsLLQsEQQPsWT S11-p
TAB1 (rat) QRRSLLQSEQQPSWT S11
S16-p
LQsEQQPsWTDDLPL
0 8
TAB1 (human) LQsEQQPsWTDDLPL S16-p
TAB1 iso2 (human) LQSEQQPSWTDDLPL S16
TAB1 (mouse) LQsEQQPsWTDDLPL S16-p
TAB1 (rat) LQSEQQPSWTDDLPL S16
K42-ub
RSYSADGkGTESHPP
0 2
TAB1 (human) RSYSADGkGTESHPP K42-ub
TAB1 iso2 (human) RSYSADGKGTESHPP K42
TAB1 (mouse) RSYSADGKGTESHPP K42
TAB1 (rat) RSYSADGKGTESHPP K42
K150-ub
QLPPQYQkILERLKT
Upstream
0 5
Treatment
  • MG132
TAB1 (human) QLPPQYQkILERLKT K150-ub
TAB1 iso2 (human) QLPPQYQKILERLKT K150
TAB1 (mouse) QLPPQYQKILERLKA K150
TAB1 (rat) QLLPQYQKILERLKA K150
Y179-p
VLLNNKLyVANVGtN
0 1
TAB1 (human) VLLNNKLyVANVGtN Y179-p
TAB1 iso2 (human) VLLNNKLYVANVGTN Y179
TAB1 (mouse) VLLNSKLYVANVGTN Y179
TAB1 (rat) VLLNNKLYVANVGTN Y179
T185-p
LyVANVGtNRALLCk
0 1
TAB1 (human) LyVANVGtNRALLCk T185-p
TAB1 iso2 (human) LYVANVGTNRALLCK T185
TAB1 (mouse) LYVANVGTNRALLCK T185
TAB1 (rat) LYVANVGTNRALLCR T185
K192-ub
tNRALLCkSTVDGLQ
0 1
TAB1 (human) tNRALLCkSTVDGLQ K192-ub
TAB1 iso2 (human) TNRALLCKSTVDGLQ K192
TAB1 (mouse) TNRALLCKSTVDGLQ K192
TAB1 (rat) TNRALLCRSTVDGLQ R192
K227-ub
QLGLDAGkIkQVGII
0 8
TAB1 (human) QLGLDAGkIkQVGII K227-ub
TAB1 iso2 (human) QLGLDAGKIKQVGII K227
TAB1 (mouse) QLGLDAGKIKQMGVI K227
TAB1 (rat) QLGLDAGKIKQVGVI K227
K229-ub
GLDAGkIkQVGIICG
0 1
TAB1 (human) GLDAGkIkQVGIICG K229-ub
TAB1 iso2 (human) GLDAGKIKQVGIICG K229
TAB1 (mouse) GLDAGKIKQMGVICG K229
TAB1 (rat) GLDAGKIKQVGVICG K229
K249-ub
RIGDYKVkYGYTDID
0 2
TAB1 (human) RIGDYKVkYGYTDID K249-ub
TAB1 iso2 (human) RIGDYKVKYGYTDID K249
TAB1 (mouse) RIGDYKVKYGYTDID K249
TAB1 (rat) RIGDYKVKYGYTDID K249
K262-ub
IDLLSAAkSkPIIAE
0 1
TAB1 (human) IDLLSAAkSkPIIAE K262-ub
TAB1 iso2 (human) IDLLSAAKSKPIIAE K262
TAB1 (mouse) IDLLSAAKSKPIIAE K262
TAB1 (rat) IDLLSTAKSKPIIAE K262
K264-ub
LLSAAkSkPIIAEPE
0 3
TAB1 (human) LLSAAkSkPIIAEPE K264-ub
TAB1 iso2 (human) LLSAAKSKPIIAEPE K264
TAB1 (mouse) LLSAAKSKPIIAEPE K264
TAB1 (rat) LLSTAKSKPIIAEPE K264
S339-p
DRVKRIHsDTFASGG
0 2
TAB1 (human) DRVKRIHsDTFASGG S339-p
TAB1 iso2 (human) DRVKRIHSDTFASGG S339
TAB1 (mouse) DRVKRIHSDTFASGG S339
TAB1 (rat) DRVKRIHSDTFASGG S339
T376-p
LGEMSQPtPsPAPAA
Upstream
0 1
Treatment
  • AZD1152
  • MLN8054
  • ZM447439
TAB1 (human) LGEMSQPtPsPAPAA T376-p
TAB1 iso2 (human) LGEMSQPTPSPAPAA T376
TAB1 (mouse) LGEMSQPTPTPAPGG T376
TAB1 (rat) LGEMSQPTPTPAPGG T376
S378-p
EMSQPtPsPAPAAGG
Upstream
0 8
Regulatory protein:
  • TAK1 (human)
Treatment
  • AZD1152
  • bacterial infection
  • MLN8054
  • selumetinib
  • vemurafenib
  • ZM447439
TAB1 (human) EMSQPtPsPAPAAGG S378-p
TAB1 iso2 (human) EMSQPTPSPAPAAGG S378
TAB1 (mouse) EMSQPTPTPAPGGRV T378
TAB1 (rat) EMSQPTPTPAPGGRV T378
S395-gl
YPVSVPYsSAQSTSK
Upstream
1 2
Treatment
  • hypertonic_buffer
  • IL-1a
TAB1 (human) YPVSVPYsSAQSTSK S395-gl
TAB1 iso2 (human) YPVSVPYSSAQSTSK S395
TAB1 (mouse) YPVSVPYssAQSTSK S393-gl
TAB1 (rat) YPVSVPYSSAQSTSK S393
S396
PVSVPYsSAQSTSKT
0 1
TAB1 (human) PVSVPYsSAQSTSKT S396
TAB1 iso2 (human) PVSVPYSSAQSTSKT S396
TAB1 (mouse) PVSVPYssAQSTSKT S394-gl
TAB1 (rat) PVSVPYSSAQSTSKT S394
S423-p
QMVNGAHsASTLDEA
Upstream
Downstream
7 0
Effects on Modified Protein
  • activity, inhibited
  • phosphorylation
Kinase, in vitro:
  • P38A (human)
Putative in vivo kinases:
  • P38A (human)
Treatment
  • anisomycin
  • BIRB-0796
  • EGF
  • H2O2
  • IL-1a
  • IL-1b
  • LPS
  • MMS
  • PD184352
  • SB203580
  • sorbitol
  • TNF
  • UV
TAB1 (human) QMVNGAHsASTLDEA S423-p
TAB1 iso2 (human) QMVNGAHSASTLDEA S423
TAB1 (mouse) QMVNGSHSASTLDEA S421
TAB1 (rat) QMVNGSHSASTLDEA S421
T431-p
ASTLDEAtPTLTNQs
Upstream
Downstream
6 1
Effects on Modified Protein
  • activity, inhibited
  • phosphorylation
Kinase, in vitro:
  • P38A (human)
Putative in vivo kinases:
  • P38A (human)
Treatment
  • anisomycin
  • anti-CD3/CD28
  • EGF
  • H2O2
  • IL-1a
  • LPS
  • PD184352
  • SB203580
  • sorbitol
  • TNF
  • UV
TAB1 (human) ASTLDEAtPTLTNQs T431-p
TAB1 iso2 (human) ASTLDEATPTLTKDP T431
TAB1 (mouse) ASTLDEATPTLTNQS T429
TAB1 (rat) ASTLDEATPTLTNQS T429
S438-p
tPTLTNQsPTLtLQS
Upstream
Downstream
7 1
Effects on Modified Protein
  • phosphorylation
Effects on Biological Processes:
  • signaling pathway regulation
Kinase, in vitro:
  • P38A (human)
Phosphatases, in vitro:
  • DUSP14 (human)
Putative in vivo kinases:
  • ERK1 (human)
  • ERK2 (human)
  • JNK1 (human)
  • JNK2 (human)
Putative upstream phosphatases:
  • DUSP14 (human)
Regulatory protein:
  • JNK1 (human)
  • JNK2 (human)
  • yopJ (bacteria)
Treatment
  • anisomycin
  • anti-CD3/CD28
  • H2O2
  • IL-1a
  • IL-1b
  • ionomycin
  • LPS
  • PD184352
  • phorbol_ester
  • SB203580
  • sorbitol
  • TNF
  • UV
TAB1 (human) tPTLTNQsPTLtLQS S438-p
TAB1 iso2 (human) gap -
TAB1 (mouse) TPTLTNQSPTLTLQS S436
TAB1 (rat) TPTLTNQSPTLTLQS S436
T442-p
TNQsPTLtLQSTNTH
0 1
TAB1 (human) TNQsPTLtLQSTNTH T442-p
TAB1 iso2 (human) gap -
TAB1 (mouse) TNQSPTLTLQSTNTH T440
TAB1 (rat) TNQSPTLTLQSTNTH T440
S452-p
STNTHTQssSSssDG
Upstream
Downstream
1 0
Effects on Modified Protein
  • enzymatic activity, induced
  • intracellular localization
  • phosphorylation
Effects on Biological Processes:
  • transcription, inhibited
Kinase, in vitro:
  • P38A (human)
  • TAK1 (human)
Putative in vivo kinases:
  • P38A (human)
  • TAK1 (human)
Treatment
  • (5Z)-7-oxozeaenol
  • anisomycin
  • calyculin_A
  • sorbitol
TAB1 (human) STNTHTQssSSssDG S452-p
TAB1 iso2 (human) gap -
TAB1 (mouse) STNTHTQSSSSSSDG S450
TAB1 (rat) STNTHTQSSSSSSDG S450
S453-p
TNTHTQssSSssDGG
Upstream
Downstream
1 0
Effects on Modified Protein
  • enzymatic activity, induced
  • intracellular localization
  • phosphorylation
Effects on Biological Processes:
  • transcription, inhibited
Kinase, in vitro:
  • P38A (human)
  • TAK1 (human)
Putative in vivo kinases:
  • P38A (human)
  • TAK1 (human)
Treatment
  • (5Z)-7-oxozeaenol
  • anisomycin
  • calyculin_A
  • sorbitol
TAB1 (human) TNTHTQssSSssDGG S453-p
TAB1 iso2 (human) gap -
TAB1 (mouse) TNTHTQSSSSSSDGG S451
TAB1 (rat) TNTHTQSSSSSSDGG S451
S456-p
HTQssSSssDGGLFR
Upstream
Downstream
1 0
Effects on Modified Protein
  • enzymatic activity, induced
  • intracellular localization
  • phosphorylation
Effects on Biological Processes:
  • transcription, inhibited
Kinase, in vitro:
  • P38A (human)
  • TAK1 (human)
Putative in vivo kinases:
  • P38A (human)
  • TAK1 (human)
Treatment
  • (5Z)-7-oxozeaenol
  • anisomycin
  • calyculin_A
  • sorbitol
TAB1 (human) HTQssSSssDGGLFR S456-p
TAB1 iso2 (human) gap -
TAB1 (mouse) HTQSSSSSSDGGLFR S454
TAB1 (rat) HTQSSSSSSDGGLFR S454
S457-p
TQssSSssDGGLFRS
Upstream
Downstream
1 0
Effects on Modified Protein
  • enzymatic activity, induced
  • intracellular localization
  • phosphorylation
Effects on Biological Processes:
  • transcription, inhibited
Kinase, in vitro:
  • P38A (human)
  • TAK1 (human)
Putative in vivo kinases:
  • P38A (human)
  • TAK1 (human)
Treatment
  • (5Z)-7-oxozeaenol
  • anisomycin
  • calyculin_A
  • sorbitol
TAB1 (human) TQssSSssDGGLFRS S457-p
TAB1 iso2 (human) gap -
TAB1 (mouse) TQSSSSSSDGGLFRS S455
TAB1 (rat) TQSSSSSSDGGLFRS S455
S469-p
FRSRPAHsLPPGEDG
0 2
TAB1 (human) FRSRPAHsLPPGEDG S469-p
TAB1 iso2 (human) gap -
TAB1 (mouse) FRSRPAHSLPPGEDG S467
TAB1 (rat) FRSRPAHSLPPGEDG S467
Y481-p
EDGRVEPyVDFAEFy
0 19
TAB1 (human) EDGRVEPyVDFAEFy Y481-p
TAB1 iso2 (human) gap -
TAB1 (mouse) EDGRVEPYVDFAEFY Y479
TAB1 (rat) EDGRVEPYVDFAEFY Y479
Y488-p
yVDFAEFyRLWsVDH
0 1
TAB1 (human) yVDFAEFyRLWsVDH Y488-p
TAB1 iso2 (human) gap -
TAB1 (mouse) YVDFAEFYRLWSVDH Y486
TAB1 (rat) YVDFAEFYRLWSVDH Y486
S492-p
AEFyRLWsVDHGEQS
0 1
TAB1 (human) AEFyRLWsVDHGEQS S492-p
TAB1 iso2 (human) gap -
TAB1 (mouse) AEFYRLWSVDHGEQS S490
TAB1 (rat) AEFYRLWSVDHGEQS S490